Amphiphilic nebramine analogs synergize with β-lactam/β-lactamase inhibitor combinations, including cefepime–taniborbactam and meropenem–xeruborbactam against metallo-β-lactamase-carrying Pseudomonas aeruginosa
RSC Medicinal Chemistry · 2025 · 16 (9) · 4492-4509
DOI: 10.1039/d5md00375j ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Medicinal Chemistry, 2025. Verfasst von Christian Lozeau und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Manitoba Winnipeg MB R3T 2N2 Canada lozeauc@myumanitoba.ca ramirezd@myumanitoba.ca ramiredm@myumanitoba.ca gul…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada.
Abstract (Originalsprache)
Cefepime–taniborbactam (FEP–TAN) and meropenem–xeruborbactam (MEM–XER) are β-lactam–β-lactamase inhibitor (BL–BLI) combinations currently in development and both projected to treat metallo-β-lactamase (MBL)-producing Gram-negative pathogens.
Autor:innen und Institutionen
- Department of Chemistry, University of Manitoba Winnipeg MB R3T 2N2 Canada lozeauc@myumanitoba.ca ramirezd@myumanitoba.ca ramiredm@myumanitoba.ca gulshan.kumar@umanitoba.ca arorar5@myumanitoba.ca frank.schweizer@cc.uman…
- Department of Medical Microbiology and Infectious Diseases, University of Manitoba Winnipeg MB R3E 0J9 Canada ggzhanel@pcsinternet.ca.
- Department of Biochemistry and Medical Genetics, University of Manitoba Winnipeg MB R3E 0J9 Canada gilbert.arthur@umanitoba.ca.
ORCID-Profile: Christian Lozeau, Rajat Arora, Frank Schweizer
Förderung
- Canadian Institutes of Health Research
- Natural Sciences and Engineering Research Council of Canada
Zitieren
APA
Lozeau, C., Ramirez, D., Ramirez, D., Kumar, G., Arora, R., Zhanel, G., Arthur, G., & Schweizer, F. (2025). Amphiphilic nebramine analogs synergize with β-lactam/β-lactamase inhibitor combinations, including cefepime–taniborbactam and meropenem–xeruborbactam against metallo-β-lactamase-carrying Pseudomonas aeruginosa. RSC Medicinal Chemistry, 16(9), 4492-4509. https://doi.org/10.1039/d5md00375j
Vancouver
Lozeau C, Ramirez D, Ramirez D, Kumar G, Arora R, Zhanel G, et al. Amphiphilic nebramine analogs synergize with β-lactam/β-lactamase inhibitor combinations, including cefepime–taniborbactam and meropenem–xeruborbactam against metallo-β-lactamase-carrying Pseudomonas aeruginosa. RSC Medicinal Chemistry. 2025;16(9):4492-4509. doi:10.1039/d5md00375j
BibTeX
@article{Lozeau2025,
author = {Lozeau, Christian and Ramirez, Danzel and Ramirez, Danyel and Kumar, Gulshan and Arora, Rajat and Zhanel, George and Arthur, Gilbert and Schweizer, Frank},
title = {Amphiphilic nebramine analogs synergize with β-lactam/β-lactamase inhibitor combinations, including cefepime–taniborbactam and meropenem–xeruborbactam against metallo-β-lactamase-carrying Pseudomonas aeruginosa},
journal = {RSC Medicinal Chemistry},
year = {2025},
volume = {16},
number = {9},
pages = {4492--4509},
doi = {10.1039/d5md00375j}
}
EUVIMED